BCEL Atreca Inc.

16.65
+0.55  (+3%)
Previous Close 16.1
Open 16.05
Price To Book 2.13
Market Cap 465,330,354
Shares 27,947,769
Volume 162,577
Short Ratio
Av. Daily Volume 119,356

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b trial to be initiated early 2020.
ATRC-101
Solid tumors